质母细胞瘤中CD97 (ADGRE5) 的表达特征和瘤发生机制使其成为可向的脆弱性
Niklas Ravn-Boess1, Nainita Roy2, Takamitsu Hattori3
1Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY 10016, USA.
Cell reports
|November 8, 2023
概括
CD97 (ADGRE5) 是一种有前途的质母细胞瘤 (GBM) 治疗标. 向CD97抑制GBM的生长和新陈代谢,为这种侵袭性脑癌提供了一个新的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 质母细胞瘤 (GBM) 是一种高度侵袭性的原发性脑瘤.
- 粘附G蛋白结合受体 (aGPCRs) 正在成为瘤学中的潜在治疗点.
- 与健康的大脑组织相比,CD97 (ADGRE5) 在GBM中表现出de novo表达.
研究的目的:
- 研究CD97 (ADGRE5) 作为质母细胞瘤 (GBM) 的治疗点.
- 阐明CD97在GBM瘤启动,代谢和信号通路中的作用.
- 评估针对GBM中的CD97的治疗潜力.
主要方法:
- 在体外和体内研究中利用患者衍生的GBM培养物 (PDGCs).
- 进行了CD97的淘汰和淘汰实验.
- 研究了基激活蛋白激酶 (MAPK) 途径和β-arrestin的招募.
- 确定THY1/CD90作为一个潜在的CD97连接体.
- 测试了一种抗CD97抗体-药物联合体,用于选择性瘤细胞杀死.
主要成果:
- CD97淘汰赛/淘汰赛显著降低了GBM瘤启动能力.
- CD97通过MAPK途径促进GBM的糖分代谢,这取决于C端酸化和β-arrestin.
- 在GBM中,THY1/CD90被确定为可能的CD97连接体.
- 一种抗CD97抗体-药物结合体在体外证明了选择性杀死GBM细胞.
结论:
- CD97 (ADGRE5) 是GBM中瘤代谢的关键调节者.
- 了解CD97的激活和信号提供了机械的洞察力.
- 这些发现为开发针对CD97的生物药物用于GBM治疗提供了强有力的理由.
关键词:
在ADGRE5中,ADGRE5是最重要的.在CD97 CD97 CD97 CD97 CD97 CD97 CD97CP: 癌症 癌症 癌症华堡代谢的代谢过程粘附性G蛋白合受体受体的粘附性抗体与药物结合物的结合物.质母细胞瘤 (glioblastoma) 是一种接收器信号传输接收器更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
